CMXHF:OTCMKTS
CSL Ltd
USD 121,10
0,00%
(0,00) 1D
9 Okt., 12:22:41 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CMXHF...
Mkt. cap
88,58 mjd
Avg. vol.
167,00
Volume
0,00
52-wk high
USD 148,36
52-wk low
USD 63,84
Beta
0,56
Shares outstanding
479,88 m
No. of employees
29 k
Mkt. cap
88,58 mjd
Avg. vol.
167,00
Volume
0,00
52-wk high
USD 148,36
52-wk low
USD 63,84
Beta
0,56
Shares outstanding
479,88 m
No. of employees
29 k
News stories
From web sources and news partners
ad-hoc-news.de
·
1 dag gelede
CSL sets October 27 AGM in Melbourne for CSL stock
ad-hoc-news.de
·
2 dae gelede
CSL stock trades at EUR 114.24 with AUD 88.5 billion market cap
ad-hoc-news.de
·
2 dae gelede
CSL signs rare-disease deal and CSL stock costs EUR 114.58
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29 k
Founded1916
HeadquartersMelbourne, Victoria, Australië
Sector-
Websitecsl.com